| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4310220 | Surgery | 2006 | 7 Pages |
Abstract
The suppressed production of angiogenic growth factors in MSI cancers partly might explain the better prognosis in MSI-positive patients. The interleukin-6 network, which upregulates production of vascular endothelial growth factor and HGF, might be involved in this mechanism.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Yasuhiro MD, Chikao MD, Hideki MD, Eiki MD, Masato MD,